303P EO2401 (EO) therapeutic vaccine for patients (pts) with recurrent glioblastoma (GB): Phase I/II ROSALIE study

Autor: Reardon, D.A., Idbaih, A., Vieito Villar, M., Tabatabai, G., Stradella, A., Ghiringhelli, F., Burger, M., Gonzalez Rodriguez, M., Hervieu, A., Mildenberger, I., Gil Martín, M., Renovanz, M., Touat, M., Wen, P., Wick, A., Gouttefangeas, C., Maia, A., Bonny, C., Fagerberg, J., Wick, W.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S676-S676
Databáze: ScienceDirect